HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

threonyl-glycine

Also Known As:

Thr-Gly; threonylglycine

Networked: 6 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - Dipeptides: 945
      - threonyl-glycine: 6

Experts

1.	Kato, Fusao: 1 article (07/2022)
2.	Nagase, Masashi: 1 article (07/2022)
3.	Okamoto, Aikou: 1 article (07/2022)
4.	Sato, Naoko: 1 article (07/2022)
5.	Suzuki, Jiro: 1 article (07/2022)
6.	Takahashi, Yukari: 1 article (07/2022)
7.	Dewey, William L: 1 article (07/2007)
8.	Gabra, Bichoy H: 1 article (07/2007)
9.	Kessler, Fay K: 1 article (07/2007)
10.	Ritter, Joseph K: 1 article (07/2007)

Related Diseases

1.	Hypokinesia (Bradykinesia) 06/01/1990 - "The intrathecal administration of high (1.05 mumol) doses of D-Ala2-Met5-enkephalinamide (DAMA), D-Ala2-Leu5-enkephalinamide (DADLE), Try-D-Thr-Gly-Phe-Leu-Thr, MR2034-TA, dextrorphan tartrate, U50,488H, levorphanol tartrate, methadone hydrochloride, and 1-methyl-4-phenyl-4-propionoxypiperidine induced spinal hypokinesia. "
2.	Seizures (Absence Seizure) 04/09/1986 - "DAGO (Tyr-D X Ala-Gly-N X Me X Phe-Gly-ol), the mu-selective peptide, produced repetitive paroxysmal discharges organized in a pattern analogous to that seen in tonic clonic seizures at doses which produced analgesia while DTLET (Tyr-D X Thr-Gly-Phe-Leu-Thr), the delta-selective peptide, produced 'petit-mal'-like seizures at doses which caused neither analgesia nor catatonia. "
3.	Pain (Aches) 01/01/2023 - "We examined whether the responses of cells in the central amygdala (CeA), an OT receptor-rich limbic site involved in pain and fear memory regulation, to exogenously applied OT analogue, Thr-Gly-OT (TGOT), vary depending on delivery. "
4.	Hyperalgesia 07/01/2007 - "with CGS 19755 (selective antagonist of the NMDAR), CGP 78608 [[(1S)-1-[[(7-bromo-1,2,3,4-tetrahydro-2,3-dioxo-5-quinoxalinyl)methyl]amino]ethyl]phosphonic acid] (selective antagonist at the glycine-binding site of the NMDAR), ifenprodil and Ro 25-6981 (selective antagonists of the NR2B subunit of the NMDAR), bisindolylmaleimide I and Go-7874 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] (inhibitors of protein kinase C), or PKI-(14-22)-amide [Myr-N-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH(2)] (inhibitor of protein kinase A) dose-dependently inhibited the hyperalgesia induced by i.t. "
5.	Catatonia 04/09/1986 - "DAGO (Tyr-D X Ala-Gly-N X Me X Phe-Gly-ol), the mu-selective peptide, produced repetitive paroxysmal discharges organized in a pattern analogous to that seen in tonic clonic seizures at doses which produced analgesia while DTLET (Tyr-D X Thr-Gly-Phe-Leu-Thr), the delta-selective peptide, produced 'petit-mal'-like seizures at doses which caused neither analgesia nor catatonia. "

Related Drugs and Biologics

1.	phenylalanylleucine
2.	Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)
3.	(trans)-Isomer 3,4- Dichloro- N- methyl- N- (2- (1- pyrrolidinyl)- cyclohexyl)- benzeneacetamide
4.	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)
5.	Leucine-2-Alanine Enkephalin (Enkephalin, Leucine 2 Alanine)
6.	Protein Kinase C
7.	Peptides (Polypeptides)
8.	Methadone (Dolophine)
9.	Levorphanol (Levo-Dromoran)
10.	Glycine (Aminoacetic Acid)

Related Therapies and Procedures

1.	Analgesia